Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer

NEXT STORY
Novan Announces Final Week-12 Visit for Last Patient in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
PREV STORY
MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Evelo Biosciences Reports Second Quarter 2018 Financial Results and Recent Business Highlights

-- Advancing Multiple Product Candidates into Clinical Trials with Dosing of First Patient in ...

author_avatar
NASDAQ Market News

Tyme Provides Clinical and Corporate Update for Fiscal Third Quarter 2017

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage ...

author_avatar
NASDAQ Market News

Radius Health to Announce First Quarter 2016 Financial Results, Host Conference Call and Live Webcast on May 5, 2016

WALTHAM, Mass., April 12, 2016 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that ...

author_avatar
NASDAQ Market News